However, the exact patterns of Aβ, tau and other disease factors’ neuronal activity alterations in AD’s neurodegenerative progression are unclear as in vivo and non-invasive measuring of neuronal excitability in human subjects remains impractical. This evidence concerns the gene MAPT and Alzheimer disease.